June 26, 2017 - By test
ABIOMED, Inc. is a provider of temporary percutaneous mechanical circulatory support devices. The company has market cap of $6.25 billion. The Firm offers care to heart failure patients. It has a 123 P/E ratio. The Firm operates in the segment of the research, development and sale of medical devices to assist or replace the pumping function of the failing heart.
Kcg Holdings Inc decreased Synnex Corp (SNX) stake by 37.13% reported in 2016Q4 SEC filing. Kcg Holdings Inc sold 8,372 shares as Synnex Corp (SNX)’s stock declined 8.02%. The Kcg Holdings Inc holds 14,175 shares with $1.72M value, down from 22,547 last quarter. Synnex Corp now has $5.36B valuation. The stock declined 0.63% or $0.81 reaching $127.56 per share. About 167,364 shares traded. SYNNEX Corporation (NYSE:SNX) has risen 29.93% since June 26, 2016 and is uptrending. It has outperformed by 13.23% the S&P500.
Since January 1, 0001, it had 0 insider buys, and 6 insider sales for $10.61 million activity.
About 121,925 shares traded. ABIOMED, Inc. (ABMD) has risen 40.97% since June 26, 2016 and is uptrending. It has outperformed by 24.27% the S&P500.
Palo Alto Investors Llc holds 12.24% of its portfolio in ABIOMED, Inc. for 1.90 million shares. Sectoral Asset Management Inc owns 251,416 shares or 3.14% of their US portfolio. Moreover, Next Century Growth Investors Llc has 2.74% invested in the company for 397,050 shares. The Massachusetts-based Granahan Investment Management Inc Ma has invested 2.22% in the stock. Rhenman & Partners Asset Management Ab, a Sweden-based fund reported 102,700 shares.
Ratings analysis reveals 100% of Abiomed’s analysts are positive. Out of 2 Wall Street analysts rating Abiomed, 2 give it “Buy”, 0 “Sell” rating, while 0 recommend “Hold”. ABMD was included in 2 notes of analysts from December 7, 2016. The stock of ABIOMED, Inc. (NASDAQ:ABMD) has “Overweight” rating given on Thursday, April 6 by Piper Jaffray. The rating was initiated by Guggenheim on Wednesday, December 7 with “Buy”.
Since January 3, 2017, it had 0 buys, and 30 sales for $4.85 million activity. POLK DENNIS sold $256,546 worth of stock or 2,358 shares. $217,360 worth of SYNNEX Corporation (NYSE:SNX) shares were sold by MURAI KEVIN M. $485,219 worth of SYNNEX Corporation (NYSE:SNX) was sold by LAROCQUE PETER on Friday, January 13. LEUNG SIMON had sold 884 shares worth $106,251. ZITZNER DUANE E had sold 3,000 shares worth $362,460. BREIDENBACH FRED A had sold 390 shares worth $46,800 on Wednesday, March 15.
Investors sentiment decreased to 0.78 in 2016 Q4. Its down 0.54, from 1.32 in 2016Q3. It is negative, as 28 investors sold SNX shares while 85 reduced holdings. 26 funds opened positions while 62 raised stakes. 28.31 million shares or 4.26% less from 29.57 million shares in 2016Q3 were reported. 38,200 were accumulated by Lsv Asset Management. 33,564 are owned by Teachers Retirement Of The State Of Kentucky. 36,090 were reported by Bancorporation Of Montreal Can. Vanguard Gp Inc has invested 0.02% in SYNNEX Corporation (NYSE:SNX). Us Savings Bank De owns 828 shares. Barclays Public Limited Liability Corporation holds 0% of its portfolio in SYNNEX Corporation (NYSE:SNX) for 5,539 shares. Morgan Stanley reported 169,239 shares or 0.01% of all its holdings. Tiaa Cref Mgmt Limited Company owns 105,930 shares or 0.01% of their US portfolio. 8,801 are held by Cap One Association. Ls Invest Advsr Limited Liability Corporation reported 0.02% in SYNNEX Corporation (NYSE:SNX). Alpha Windward Ltd Limited Liability Company holds 0.32% or 4,020 shares in its portfolio. Airain Ltd stated it has 0.07% of its portfolio in SYNNEX Corporation (NYSE:SNX). Reilly Financial Advsrs Limited Co owns 600 shares. Ubs Asset Americas Inc owns 0% invested in SYNNEX Corporation (NYSE:SNX) for 12,839 shares. Riverhead Cap Management stated it has 0.01% of its portfolio in SYNNEX Corporation (NYSE:SNX).
Among 8 analysts covering SYNNEX (NYSE:SNX), 3 have Buy rating, 2 Sell and 3 Hold. Therefore 38% are positive. SYNNEX had 18 analyst reports since August 20, 2015 according to SRatingsIntel. The stock of SYNNEX Corporation (NYSE:SNX) has “Underperform” rating given on Thursday, October 29 by Credit Agricole. The rating was maintained by Stifel Nicolaus with “Buy” on Friday, June 9. The stock of SYNNEX Corporation (NYSE:SNX) earned “Hold” rating by Needham on Tuesday, September 29. Stifel Nicolaus upgraded the stock to “Buy” rating in Wednesday, April 12 report. As per Thursday, August 27, the company rating was upgraded by Zacks. As per Wednesday, March 23, the company rating was downgraded by Raymond James. The rating was downgraded by CLSA on Thursday, October 29 to “Underperform”. On Tuesday, September 27 the stock rating was maintained by Stifel Nicolaus with “Hold”. Brean Capital maintained the shares of SNX in report on Friday, June 24 with “Buy” rating. The stock has “Buy” rating by Brean Capital on Friday, September 25.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.